• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

华法林对大鼠肝微粒体中维生素K 2,3-环氧化物还原酶的抑制作用。

Warfarin inhibition of vitamin K 2,3-epoxide reductase in rat liver microsomes.

作者信息

Fasco M J, Principe L M, Walsh W A, Friedman P A

出版信息

Biochemistry. 1983 Nov 22;22(24):5655-60. doi: 10.1021/bi00293a031.

DOI:10.1021/bi00293a031
PMID:6652076
Abstract

Warfarin is a potent inhibitor of vitamin K 2,3-epoxide reduction to vitamin K in vitro and in vivo. Dithiothreitol, an in vitro reductant for the vitamin K 2,3-epoxide reductase, antagonizes inhibition of the reductase by warfarin via mechanisms that have not been determined [Zimmermann, A., & Matschiner, J. T. (1974) Biochem. Pharmacol. 23, 1033-1040]. Experiments with rat hepatic microsomes were undertaken to characterize the interactions that exist between vitamin K 2,3-epoxide, warfarin, and dithiothreitol. Increasing concentrations of dithiothreitol decreased inhibition of the reductase by warfarin. When dithiothreitol was present prior to exposure of the reductase to warfarin, there was less inhibition than when the same concentration of dithiothreitol was present after its exposure to warfarin. Moreover, maximum inhibition of the reductase by warfarin occurred at a much slower rate when dithiothreitol was present initially. Inhibition of the reductase by warfarin was greater when the substrate concentration was 100 microM vitamin K 2,3-epoxide than when it was 10 microM epoxide. On the basis of these data, we conclude that (i) dithiothreitol reduces either directly or indirectly a critical disulfide within the reductase that it reoxidized during reduction of the epoxide substrate, (ii) warfarin and vitamin K 2,3-epoxide are not competitive with respect to one another, and (iii) warfarin binding, which produces inhibition, occurs solely to the disulfide form of the reductase. Once it is bound, warfarin inhibits further reduction of the critical disulfide by dithiothreitol. Dithiothreitol therefore antagonizes warfarin by maintaining the reductase in the reduced state.

摘要

华法林在体内外均是维生素K 2,3 - 环氧化物还原为维生素K的强效抑制剂。二硫苏糖醇是维生素K 2,3 - 环氧化物还原酶的体外还原剂,它通过尚未明确的机制对抗华法林对该还原酶的抑制作用[齐默尔曼,A.,& 马施纳,J. T.(1974年)《生物化学与药理学》23卷,第1033 - 1040页]。开展了大鼠肝微粒体实验,以表征维生素K 2,3 - 环氧化物、华法林和二硫苏糖醇之间存在的相互作用。二硫苏糖醇浓度的增加降低了华法林对还原酶的抑制作用。当在还原酶接触华法林之前存在二硫苏糖醇时,抑制作用比在其接触华法林后存在相同浓度二硫苏糖醇时要小。此外,当初始存在二硫苏糖醇时,华法林对还原酶的最大抑制作用出现的速度要慢得多。当底物浓度为100微摩尔维生素K 2,3 - 环氧化物时,华法林对还原酶的抑制作用比对10微摩尔环氧化物时更大。基于这些数据,我们得出以下结论:(i)二硫苏糖醇直接或间接还原还原酶内一个关键的二硫键,该二硫键在环氧化物底物还原过程中被重新氧化;(ii)华法林和维生素K 2,3 - 环氧化物彼此之间不存在竞争关系;(iii)产生抑制作用的华法林结合仅发生在还原酶的二硫键形式上。一旦结合,华法林会抑制二硫苏糖醇对关键二硫键的进一步还原。因此,二硫苏糖醇通过使还原酶保持还原状态来对抗华法林。

相似文献

1
Warfarin inhibition of vitamin K 2,3-epoxide reductase in rat liver microsomes.华法林对大鼠肝微粒体中维生素K 2,3-环氧化物还原酶的抑制作用。
Biochemistry. 1983 Nov 22;22(24):5655-60. doi: 10.1021/bi00293a031.
2
Lapachol inhibition of vitamin K epoxide reductase and vitamin K quinone reductase.
Arch Biochem Biophys. 1984 Nov 1;234(2):405-12. doi: 10.1016/0003-9861(84)90286-8.
3
Tissue distribution and warfarin sensitivity of vitamin K epoxide reductase.维生素K环氧化物还原酶的组织分布及对华法林的敏感性
Biochem Pharmacol. 1988 Mar 1;37(5):929-34. doi: 10.1016/0006-2952(88)90183-9.
4
Microsomal warfarin binding and vitamin K 2,3-epoxide reductase.
Biochem Pharmacol. 1989 Apr 1;38(7):1115-20. doi: 10.1016/0006-2952(89)90257-8.
5
Purification of a vitamin K epoxide reductase that catalyzes conversion of vitamin K 2,3-epoxide to 3-hydroxy-2-methyl-3-phytyl-2,3-dihydronaphthoquinone.一种催化维生素K 2,3-环氧化物转化为3-羟基-2-甲基-3-植基-2,3-二氢萘醌的维生素K环氧化物还原酶的纯化。
Proc Natl Acad Sci U S A. 1985 May;82(9):2713-7. doi: 10.1073/pnas.82.9.2713.
6
Indirect inhibition of vitamin K epoxide reduction by salicylate.水杨酸盐对维生素K环氧化物还原的间接抑制作用。
J Pharm Pharmacol. 1984 Sep;36(9):586-91. doi: 10.1111/j.2042-7158.1984.tb04903.x.
7
Species comparison of vitamin K1 2,3-epoxide reductase activity in vitro: kinetics and warfarin inhibition.维生素K1 2,3-环氧化物还原酶体外活性的物种比较:动力学与华法林抑制作用
Toxicology. 2003 Aug 1;189(3):191-8. doi: 10.1016/s0300-483x(03)00133-1.
8
Effect of N-methyl-thiotetrazole on vitamin K epoxide reductase.N-甲基硫代四氮唑对维生素K环氧化物还原酶的影响。
Thromb Res. 1986 Oct 15;44(2):147-53. doi: 10.1016/0049-3848(86)90130-1.
9
Vitamin K 2,3-epoxide reductase: the basis for stereoselectivity of 4-hydroxycoumarin anticoagulant activity.维生素K 2,3-环氧化物还原酶:4-羟基香豆素抗凝活性立体选择性的基础。
Br J Pharmacol. 1988 Nov;95(3):675-82. doi: 10.1111/j.1476-5381.1988.tb11692.x.
10
Evidence that warfarin anticoagulant action involves two distinct reductase activities.华法林抗凝作用涉及两种不同还原酶活性的证据。
J Biol Chem. 1982 Oct 10;257(19):11210-2.

引用本文的文献

1
Antioxidants: a comprehensive review.抗氧化剂:全面综述。
Arch Toxicol. 2025 May;99(5):1893-1997. doi: 10.1007/s00204-025-03997-2. Epub 2025 Apr 15.
2
Missense VKOR mutants exhibit severe warfarin resistance but lack VKCFD via shifting to an aberrantly reduced state.错义 VKOR 突变体表现出严重的华法林耐药性,但由于异常降低状态而缺乏 VKCFD。
Blood Adv. 2023 May 23;7(10):2271-2282. doi: 10.1182/bloodadvances.2021006876.
3
Stabilization and structure determination of integral membrane proteins by termini restraining.通过末端限制实现整合膜蛋白的稳定化及结构测定。
Nat Protoc. 2022 Feb;17(2):540-565. doi: 10.1038/s41596-021-00656-5. Epub 2022 Jan 17.
4
Biochemical Studies of Mitochondrial Malate: Quinone Oxidoreductase from .线粒体苹果酸的生化研究:来自. 的醌氧化还原酶
Int J Mol Sci. 2021 Jul 22;22(15):7830. doi: 10.3390/ijms22157830.
5
Chiral liquid chromatography-tandem mass spectrometry analysis of superwarfarin rodenticide stereoisomers - Bromadiolone, difenacoum and brodifacoum - In human plasma.手性液相色谱-串联质谱法分析超级杀鼠剂立体异构体——溴敌隆、杀鼠醚和溴鼠灵——在人血浆中的应用。
J Chromatogr B Analyt Technol Biomed Life Sci. 2021 Feb 15;1165:122529. doi: 10.1016/j.jchromb.2021.122529. Epub 2021 Jan 7.
6
The catalytic mechanism of vitamin K epoxide reduction in a cellular environment.细胞环境中维生素 K 环氧化物还原的催化机制。
J Biol Chem. 2021 Jan-Jun;296:100145. doi: 10.1074/jbc.RA120.015401. Epub 2020 Dec 10.
7
Separation and Quantification of Superwarfarin Rodenticide Diastereomers-Bromadiolone, Difenacoum, Flocoumafen, Brodifacoum, and Difethialone-in Human Plasma.人血浆中超杀鼠灵类杀鼠剂非对映异构体——溴敌隆、敌鼠、氟鼠酮、溴鼠灵和二氟噻隆——的分离与定量分析
J AOAC Int. 2020 Jun 1;103(3):770-778. doi: 10.1093/jaoacint/qsaa007.
8
Characterization of Warfarin Inhibition Kinetics Requires Stabilization of Intramembrane Vitamin K Epoxide Reductases.表征华法林抑制动力学需要稳定膜内维生素 K 环氧化物还原酶。
J Mol Biol. 2020 Aug 21;432(18):5197-5208. doi: 10.1016/j.jmb.2020.05.009. Epub 2020 May 20.
9
Competitive tight-binding inhibition of VKORC1 underlies warfarin dosage variation and antidotal efficacy.维生素K环氧化物还原酶复合体1(VKORC1)的竞争性紧密结合抑制是华法林剂量变化和解毒功效的基础。
Blood Adv. 2020 May 26;4(10):2202-2212. doi: 10.1182/bloodadvances.2020001750.
10
A cell-based high-throughput screen identifies drugs that cause bleeding disorders by off-targeting the vitamin K cycle.基于细胞的高通量筛选可通过靶向维生素 K 循环来识别导致出血性疾病的药物。
Blood. 2020 Aug 13;136(7):898-908. doi: 10.1182/blood.2019004234.